WebMOLECULAR CANCER THERAPEUTICS. 出版年份:2001 年文章数:226 投稿命中率:31.11%. 出版周期:Monthly 自引率:2.9% 审稿周期:平均2.73月. 前往期刊查询. 期刊讨论 中国SCI论文 期刊主页 投稿经验 杂志官网 投稿链接 作者需知 PMC链接 Pubmed全文检索. 期刊论坛. 期刊 ... Web《current gene therapy》发布于爱科学网,并永久归类相关sci期刊导航类别中,本站只是硬性分析 "《curr gene ther》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。"《curr gene ther》" 的价值还取决于各种因素的综合分析。
Post-baccalaureate Fellow - Neuro-endocrine cancer, translational ...
WebApr 13, 2024 · SAN DIEGO, April 13, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and ... inbound informatica
解刊 《Cancer Medicine》 - 知乎
Web期刊简称(nlm): cancer gene ther 期刊备注: issn刊号: 0929-1903 研究方向: 医学 2024-2024最新影响因子: 4.681 sci类别: sci/scie 是否oa开放访问: no 出版地: england 出版周期: monthly 创刊年份: 1994 ... WebMolecular Therapy's 2024 impact factor is 8.986. Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine …. WebCancer Gene Therapy 2024-2024 年的影响因子为5.854。. Cancer Gene Therapy 最新 … inbound information